Triazine Compound Salt Crystal Form, Tanabe Pharma, EP4215244A1, Apr 15 2026
Summary
The European Patent Office published patent EP4215244A1 on April 15, 2026, covering triazine compound salt crystal forms and production methods. The patent is assigned to Tanabe Pharma Corporation with four named inventors: Yamagami, Setsuta, Sugiura, and Ueda. The patent is designated across 31 European states including DE, FR, GB, IT, NL, ES, and SE.
About this source
GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
The European Patent Office granted patent EP4215244A1 to Tanabe Pharma Corporation on April 15, 2026. The patent covers triazine compound salt crystal forms and methods of production, with designations across 31 European states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.\n\nTanabe Pharma Corporation now holds enforceable intellectual property rights in the designated states for the triazine salt crystal form and its production method, providing 20-year patent protection from the filing date across major European pharmaceutical markets.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TRIAZINE COMPOUND SALT, CRYSTAL FORM THEREOF, AND PRODUCTION METHOD THEREFOR
Publication EP4215244A1 Kind: A1 Apr 15, 2026
Applicants
Tanabe Pharma Corporation
Inventors
YAMAGAMI, Takafumi, SETSUTA, Tomofumi, SUGIURA, Yoshihiro, UEDA, Naoko
IPC Classifications
A61P 1/16 20060101AFI20250117BHEP A61P 3/00 20060101ALI20250117BHEP A61P 3/04 20060101ALI20250117BHEP A61P 5/38 20060101ALI20250117BHEP A61P 7/00 20060101ALI20250117BHEP A61P 9/04 20060101ALI20250117BHEP A61P 9/10 20060101ALI20250117BHEP A61P 9/12 20060101ALI20250117BHEP A61P 13/12 20060101ALI20250117BHEP A61P 25/00 20060101ALI20250117BHEP A61P 27/02 20060101ALI20250117BHEP A61P 43/00 20060101ALI20250117BHEP C07D 295/15 20060101ALI20250117BHEP C07D 295/205 20060101ALI20250117BHEP C07D 253/07 20060101ALI20250117BHEP A61K 31/53 20060101ALI20250117BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.